Melanie Gloria is an experienced operations executive with a strong background in the biotechnology and pharmaceutical industries. Currently serving as Chief Operating Officer at Immunovant since November 2024, Melanie previously held the same title at ACELYRIN, INC. from November 2021 to October 2024. Prior to this, Melanie was Senior Vice President of Development Operations at Horizon, focusing on clinical operations, compliance, regulatory affairs, and safety from June 2018 to November 2021. Earlier roles include Senior Director of Clinical Program Development at AbbVie from August 2014 to July 2018 and Associate Director of Clinical Program Development at Abbott from November 2009 to August 2014.
This person is not in any teams
This person is not in any offices